Intravitreal injections (IVI) have become the most common intraocular procedure worldwide
with increasing numbers every year. The article presents the most up-to-date review on IVI …

Although once daily anti-glaucoma drug therapy is a current clinical reality, most therapies
require multiple dosing and there is an unmet need to develop convenient, safe, and …

Background: Age-related macular degeneration is a leading cause of severe, irreversible
vision impairment in developed countries. The primary risk factors for the development of …

Background Pegaptanib, an anti–vascular endothelial growth factor therapy, was evaluated
in the treatment of neovascular age-related macular degeneration. Methods We conducted …

Purpose: To review evidence and provide updated guidelines on intravitreal (IVT) injection
technique and monitoring. Methods: A review of the published literature on IVT injection from …

Purpose: To report the rates of endophthalmitis and the spectrum of causative organisms
after intravitreal injection of anti-vascular endothelial growth factor agents and possible …

Purpose: To describe the short-term anatomical and visual acuity responses after intravitreal
injection of bevacizumab (Avastin, Genentech) in patients with choroidal neovascularization …

Background Vascular endothelial growth factor (VEGF) plays an important role in many
diseases of the posterior pole that are characterized by macular edema and/or intraocular …

Purpose: To report the short-term anatomic and visual acuity response after intravitreal
injection of bevacizumab (Avastin, Genentech) in patients with proliferative diabetic …

Purpose: To report the short term anatomic and visual acuity response after intravitreal
injection of bevacizumab (Avastin, Genentech) in patients with macular edema due to …